Molina Healthcare (MOH) is up 7.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to a mix of contract momentum and renewed confidence in Molina’s earnings path rather than a single fresh headline today. Investors seem to be reacting to the company’s recent Illinois Medicaid contract win, its reaffirmed 2026 outlook and long-term growth targets, and a new analyst initiation that highlighted near-term earnings visibility.
Details:
Sources:
Molina Healthcare, Investing.com, Stock Analysis
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$MOH Insider Trading Activity
$MOH insiders have traded $MOH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:
- JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
- MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930
- RICHARD C ZORETIC purchased 800 shares for an estimated $100,128
- RONNA ROMNEY sold 506 shares for an estimated $74,341
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MOH Hedge Fund Activity
We have seen 318 institutional investors add shares of $MOH stock to their portfolio, and 437 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,476,708 shares (+63.6%) to their portfolio in Q1 2026, for an estimated $331,197,777
- AQR CAPITAL MANAGEMENT LLC added 2,452,990 shares (+597.7%) to their portfolio in Q1 2026, for an estimated $328,026,087
- HARRIS ASSOCIATES L P removed 1,368,290 shares (-58.3%) from their portfolio in Q1 2026, for an estimated $182,974,580
- 8 KNOTS MANAGEMENT, LLC added 1,146,378 shares (+inf%) to their portfolio in Q4 2025, for an estimated $198,942,438
- JANE STREET GROUP, LLC added 712,027 shares (+591.0%) to their portfolio in Q1 2026, for an estimated $95,215,810
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 679,223 shares (-34.5%) from their portfolio in Q4 2025, for an estimated $117,872,359
- MAVERICK CAPITAL LTD added 645,768 shares (+inf%) to their portfolio in Q1 2026, for an estimated $86,355,325
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MOH Analyst Ratings
Wall Street analysts have issued reports on $MOH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- Barclays issued a "Underweight" rating on 01/05/2026
To track analyst ratings and price targets for $MOH, check out Quiver Quantitative's $MOH forecast page.
$MOH Price Targets
Multiple analysts have issued price targets for $MOH recently. We have seen 12 analysts offer price targets for $MOH in the last 6 months, with a median target of $185.5.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $216.0 on 06/23/2026
- John Stansel from JP Morgan set a target price of $191.0 on 06/08/2026
- Erin Wright from Morgan Stanley set a target price of $167.0 on 06/04/2026
- Andrew Mok from Barclays set a target price of $199.0 on 05/26/2026
- A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
- Michael Ha from Baird set a target price of $163.0 on 05/11/2026
- Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.